Diagnosis of canine elbow dysplasia and treatment with extracorporeal shockwave therapy.
Lenfest MI, Jennings C, Randolph AJ, Porter I, Levine D · Journal of the American Veterinary Medical Association · 1 April 2026
ESWT is an effective noninvasive therapy for canine elbow dysplasia-related osteoarthritis.
This article presents a comprehensive video tutorial on diagnosing canine elbow dysplasia and treating secondary osteoarthritis with extracorporeal shockwave therapy (ESWT). The diagnostic approach emphasizes gait analysis combined with advanced imaging (CT or radiographs) to confirm elbow dysplasia. The treatment protocol involves systematic preparation of the treatment site through clipping, cleaning with isopropyl alcohol, and application of coupling gel. Shockwave application targets the medial and lateral aspects of the elbow joint, including the medial humeral epicondyle, medial coronoid process, and joint capsule attachments. Treatment parameters including shock number and energy flux density must be carefully documented. The authors recommend a series of three treatments followed by reassessment to evaluate therapeutic response. ESWT represents a noninvasive alternative for managing secondary elbow osteoarthritis by stimulating growth factor release and anti-inflammatory cytokine production, promoting analgesia and tissue healing. This approach offers significant clinical advantage for dogs with elbow dysplasia-related pain.
This summary was distilled by AI and may occasionally misinterpret data. Confirm critical details with the primary literature before clinical application.